Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
Spectrum Pharmaceuticals revenue
Spectrum Pharmaceuticals's revenue is $10.1 million.
What is Spectrum Pharmaceuticals's revenue?
- Spectrum Pharmaceuticals's revenue growth from 2001 to 2022 is 24,568.29%.
- Spectrum Pharmaceuticals has 235 employees, and the revenue per employee ratio is $43,038.
- Spectrum Pharmaceuticals's peak quarterly revenue was $70.1M in 2012(q4).
- Spectrum Pharmaceuticals peak revenue was $267.7M in 2012.
- Spectrum Pharmaceuticals annual revenue for 2018 was 109.3M, -14.83% growth from 2017.
- Spectrum Pharmaceuticals annual revenue for 2022 was 10.1M, -90.75% growth from 2018.
On This Page
For less than a Netflix subscription, get a new job.
Spectrum Pharmaceuticals historical revenue
Spectrum Pharmaceuticals's peak revenue was $267.7M in 2012. The peak quarterly revenue was $70.1M in 2012(q4).
Spectrum Pharmaceuticals's revenue increased from $41.0k in 2001 to $10.1M currently. That's a 24,568.29% change in annual revenue.
Spectrum Pharmaceuticals annual revenue
Spectrum Pharmaceuticals annual revenue over time
| Fiscal Year / Year | Spectrum Pharmaceuticals Revenue |
|---|---|
| 2009 | $38.0M |
| 2010 | $74.1M |
| 2011 | $193.0M |
| 2012 | $267.7M |
| 2013 | $155.9M |
| 2014 | $186.8M |
| 2015 | $162.6M |
| 2016 | $146.4M |
| 2017 | $128.4M |
| 2018 | $109.3M |
| 2022 | $10.1M |
Rate Spectrum Pharmaceuticals' financial transparency
Spectrum Pharmaceuticals annual growth
Spectrum Pharmaceuticals saw the greatest revenue growth in 2002, when revenue increased by 5,682.93%.
Spectrum Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by -90.75%.
Spectrum Pharmaceuticals annual growth rate over time
| Year | Spectrum Pharmaceuticals Growth |
|---|---|
| 2009 | 32%↑ |
| 2010 | 95%↑ |
| 2011 | 160%↑ |
| 2012 | 39%↑ |
| 2013 | -42%↓ |
| 2014 | 20%↑ |
| 2015 | -13%↓ |
| 2016 | -10%↓ |
| 2017 | -12%↓ |
| 2018 | -15%↓ |
| 2022 | -91%↓ |
Spectrum Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Spectrum Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $14.2M | $8.1M | $7.1M | $8.6M |
| 2010 | $11.1M | $12.3M | $16.7M | $33.9M |
| 2011 | $43.6M | $45.4M | $51.0M | $53.0M |
| 2012 | $59.9M | $68.7M | $69.0M | $70.1M |
| 2013 | $38.7M | $33.2M | $42.4M | $41.5M |
| 2014 | $40.1M | $46.9M | $48.0M | $51.9M |
| 2015 | $38.6M | $45.0M | $28.6M | $50.3M |
| 2016 | $43.9M | $33.9M | $33.4M | $35.2M |
| 2017 | $29.1M | $34.3M | $36.4M | $28.6M |
| 2018 | $30.5M | $24.2M | $25.3M | $29.4M |
| 2022 | - | - | - | $10.1M |
| 2023 | $15.6M | - | - | - |
Spectrum Pharmaceuticals Jobs Nearby
Do you work at Spectrum Pharmaceuticals?
Is Spectrum Pharmaceuticals transparent about its revenue structure?
Spectrum Pharmaceuticals Financial Information
| CEO | Joseph W. Turgeon |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 235 |
| Date Founded | 2002 |
| Headquarters | Henderson, Nevada |
| Number of Locations | 4 |
| Revenue | $10.1M |
| Net Income | -$75,401,000 |
| Gross Proft | $8.3M (2022) |
| EBITDA | ($91.6M) (2018) |
| PE Ratio | -20.32 |
| Tax Rate | -0.0% |
| Market Capitalization | $1.5B |
| Total Assets | $103,338,000 |
| Ticker | SPPI |
Spectrum Pharmaceuticals Jobs You Might Like
Spectrum Pharmaceuticals Financing
Spectrum Pharmaceuticals received early financing of $25.0M on 2004-04-21.
| Series | Round Size | Date |
|---|---|---|
| Post Ipo Equity | $25M | 04/2004 |
| Post Ipo Equity | $42M | 09/2005 |
| Post Ipo Equity | $30M | 05/2007 |
| Post Ipo Equity | $20M | 05/2008 |
| Grant | $978K | 11/2010 |
| Post Ipo Equity | $3M | 04/2016 |
| Post Ipo Equity | $65M | 07/2020 |
| Post Ipo Equity | $20M | 01/2022 |
Spectrum Pharmaceuticals Investors
| Investors | Security Type |
|---|---|
| SDS Capital Group | Post Ipo Equity |
| Federated Kaufmann Fund | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Endo International plc | Post Ipo Equity |
| Hanmi Pharmaceutical | Post Ipo Equity |
Spectrum Pharmaceuticals competitors
| Company Name | Average Salary | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 451 |
| Exelixis | $108,978 | $2.2B | 484 | 101 |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 14 |
| Acorda Therapeutics | $97,279 | $117.6M | 344 | - |
| Intercept Pharmaceuticals | $93,850 | $285.7M | 437 | 18 |
| Ariad Pharmaceuticals | $94,078 | $118.8M | 380 | - |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
| Pfizer | $70,868 | $63.6B | 78,500 | 254 |
| Upsher-Smith Laboratories | $63,937 | $420.0M | 550 | 3 |
| Intellia Therapeutics | $79,975 | $57.9M | 211 | 18 |
Spectrum Pharmaceuticals Revenue FAQs
Search for jobs
Related Company Revenues
Working At Related Companies
Related Company Jobs
Spectrum Pharmaceuticals Highest Paying Jobs
Zippia gives an in-depth look into the details of Spectrum Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Spectrum Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Spectrum Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Spectrum Pharmaceuticals. The data presented on this page does not represent the view of Spectrum Pharmaceuticals and its employees or that of Zippia.
Spectrum Pharmaceuticals may also be known as or be related to SPECTRUM PHARMACEUTICALS INC, Spectrum Pharmaceuticals, Spectrum Pharmaceuticals Inc, Spectrum Pharmaceuticals Inc. and Spectrum Pharmaceuticals, Inc.